Clinical Trial Update: Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System [NA]

View source ↗

Summary

A prospective multi-center randomized trial evaluating the EVAHEART®2 Left Ventricular Assist System for heart failure has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• EVAHEART®2 Left Ventricular Assist System

Snippet

Sponsor: Evaheart, Inc. | Conditions: Heart Failure | NA | Status: SUSPENDED